Intravenous Solutions Market Report 2026

Intravenous Solutions Market Overview

• Intravenous Solutions market size has reached to $14.91 billion in 2025 • Expected to grow to $21.73 billion in 2030 at a compound annual growth rate (CAGR) of 7.9% • Growth Driver: Rising Cancer Prevalence Driving The Intravenous Solutions Market • Market Trend: Innovative Syringes Transforming The Intravenous Solutions Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Intravenous Solutions Market?

Intravenous solutions are sterile liquids administered directly into a patient's bloodstream, typically for hydration, medication delivery, or nutrient supplementation. They are used in intravenous therapy to restore or maintain normal fluid volume and electrolyte balance when the oral route is impossible. The main types of products included in intravenous solutions are total parenteral nutrition and peripheral parenteral nutrition. Total parenteral nutrition (TPN) is a method of providing essential nutrients and fluids directly into the bloodstream when a person cannot eat or absorb nutrients through the digestive system. Various types of nutrients, such as carbohydrates, vitamins and minerals, single-dose amino acids, parenteral lipid emulsion, and others, are used in several applications, such as basic intravenous (IV) solution, nutritional intravenous (IV) solution, blood intravenous (IV) solution, drug intravenous (IV) solution, and irrigation intravenous (IV) solution. Several end users are hospitals, clinics, ambulatory surgery centers, and home care settings.

What Is The Intravenous Solutions Market Growth Forecast?

The intravenous solutions market size is expected to see strong growth in the next few years. It will grow to $21.73 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to expansion of home healthcare and outpatient infusion services, increasing aging population requiring nutritional support, rising adoption of personalized nutrition therapies, advancements in sterile packaging technologies, growing demand for long-term parenteral nutrition. Major trends in the forecast period include rising demand for intravenous hydration in acute and chronic care, increasing use of parenteral nutrition in critical and geriatric care, growing preference for ready-to-use iv solution formulations, expansion of home-based iv therapy and infusion services, increasing focus on sterility and safety in iv solution manufacturing.

What Are The Drivers Of The Intravenous Solutions Market?

The increasing prevalence of cancer is expected to propel the growth of the intravenous solutions market going forward. Cancer is a group of diseases characterized by uncontrolled cell growth and the ability to invade surrounding tissues and spread to other parts of the body. Intravenous solutions are commonly used in cancer treatment to deliver chemotherapy drugs and maintain hydration during therapy. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases were projected, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the increasing prevalence of cancer is driving the growth of the intravenous solutions industry. The increasing number of surgical procedures is expected to propel the growth of the intravenous solutions market going forward. Surgical procedures are any medical operations used to treat various diseases and disorders through incisions or other invasive approaches. The intravenous solutions are essential for surgical procedures, offering vital support for hydration, electrolyte balance, medication administration, and emergency interventions. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional organization representing board-certified aesthetic plastic surgeons, total surgical and non-surgical aesthetic procedures increased by 3.4% in 2023 to reach 34.9 million worldwide, with liposuction remaining the most common surgical procedure, accounting for more than 2.2 million cases. Therefore, the increasing number of surgical procedures is driving the growth of the intravenous solutions industry.

Key Players In The Global Intravenous Solutions Market

Major companies operating in the intravenous solutions market are Pfizer Inc., Abbott Laboratories, Eli Lilly and Company, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., CSL Limited, B. Braun Melsungen AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Sichuan Kelun Pharmaceutical Co. Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, ICU Medical Inc., Gland Pharma Limited, Cisen Pharmaceutical Co. Ltd., Amsino International Inc., JW Life Science Co. Ltd., Eurolife Healthcare Pvt. Ltd., Huaren Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd., Claris Lifesciences Limited, Amanta Healthcare Ltd., Axa Parenterals Ltd., Wockhardt Ltd., Liqvor pharmaceuticals cjsc, Soxa Formulations & Research Pvt.Ltd., Aculife Healthcare Pvt. Ltd.

Global Intravenous Solutions Market Trends and Insights

Major companies operating in the intravenous solutions market are focused on developing innovative syringes, such as pre-filled and ready-to-administer syringes, to gain a competitive edge in the market. Pre-filled and ready-to-administer syringes are preloaded with medication and designed for immediate use without requiring manual filling or preparation. For instance, in August 2023, GENIXUS Corp., a US-based healthcare company, launched KinetiXTM Rocuronium Bromide Injection in 5 mL and 10 mL ready-to-administer (RTA) syringes. The syringes are made of a transparent, durable polymer material that eliminates the risks associated with glass syringes. The syringes are pre-filled and ready to administer, saving time and reducing medication errors. Rocuronium bromide injection is for intravenous use only. It possesses several vital attributes, including RFID-enabled with KitCheck, the latest kit and tray management technology, intuitive labeling, and a color-coded plunger rod to support rapid identification.

What Defines the Intravenous Solutions Market?

The intravenous solutions market consists of sales of dextrose 5% in water (D5W), 0.45% sodium chloride (half normal saline), dextrose 5% in normal saline (D5NS), 0.2% sodium chloride (hypotonic saline), and dextrose 10% in water (D10W). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Intravenous Solutions Market Report 2026?

The intravenous solutions market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the intravenous solutions industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.